An Open-label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin

NCT00678743 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Dyslipidemias

Interventions

DRUG: Omacor + simvastatin

Sponsor

Provident Clinical Research

Collaborators

[object Object]